Global Frontier Investments’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-272,281
Closed -$5.89M 18
2020
Q4
$4.75M Hold
272,281
4.62% 5
2020
Q3
$3.19M Hold
272,281
4.7% 7
2020
Q2
$3.54M Buy
+272,281
New +$3.27M 5.4% 4

Global Frontier Investments's OXFD Position: Q1 2021 in Review

Global Frontier Investments sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 272,281 shares — an estimated $5.89M sold.

Global Frontier Investments first reported a position in OXFD in Q2 2020 and held it in 3 quarters. The position peaked at $4.75M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

  • Global Frontier Investments reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Global Frontier Investments sold 272,281 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $5.89M.
  • Global Frontier Investments first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2020 and held it in 3 quarters.
  • Global Frontier Investments's Oxford Immunotec Global PLC Ordinary Shares position peaked at $4.75M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Global Frontier Investments's 13F filing for Q1 2021, filed 11 May 2021.